Tech Company Financing Transactions

Precision BioSciences Funding Round

On 6/27/2018, Precision BioSciences announced $110 million in Series B investment from ArrowMark Partners, Adage Capital Management and Agent Capital.

Transaction Overview

Announced On
6/27/2018
Transaction Type
Venture Equity
Amount
$110,000,000
Round
Series B
Proceeds Purpose
Precision plans to utilize the proceeds from this financing to accelerate and expand its product portfolio.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
302 East Pettigrew St. Dibrell Building A-100
Durham, NC 27701
USA
Email Address
Overview
The Precision BioSciences (Nasdaq: DTIL) mission is to translate the world's most powerful genome editing technology into greatly needed products throughout the life sciences.
Profile
Precision BioSciences LinkedIn Company Profile
Social Media
Precision BioSciences Company Twitter Account
Company News
Precision BioSciences News
Facebook
Precision BioSciences on Facebook
YouTube
Precision BioSciences on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Matthew Kane
  Matthew Kane LinkedIn Profile  Matthew Kane Twitter Account  Matthew Kane News  Matthew Kane on Facebook
Chief Scientific Officer
Derek Jantz
  Derek Jantz LinkedIn Profile  Derek Jantz Twitter Account  Derek Jantz News  Derek Jantz on Facebook
Vice President
Clayton Beard
  Clayton Beard LinkedIn Profile  Clayton Beard Twitter Account  Clayton Beard News  Clayton Beard on Facebook
VP - Bus. Development
Drew Applefield
  Drew Applefield LinkedIn Profile  Drew Applefield Twitter Account  Drew Applefield News  Drew Applefield on Facebook
VP - Bus. Development
Michael Dombeck
  Michael Dombeck LinkedIn Profile  Michael Dombeck Twitter Account  Michael Dombeck News  Michael Dombeck on Facebook
VP - Engineering
Victor Bartsevich
  Victor Bartsevich LinkedIn Profile  Victor Bartsevich Twitter Account  Victor Bartsevich News  Victor Bartsevich on Facebook
VP - Finance
Abid Ansari
  Abid Ansari LinkedIn Profile  Abid Ansari Twitter Account  Abid Ansari News  Abid Ansari on Facebook
VP - Marketing
Heather King
  Heather King LinkedIn Profile  Heather King Twitter Account  Heather King News  Heather King on Facebook
VP - Operations
Sinu Bhandaru
  Sinu Bhandaru LinkedIn Profile  Sinu Bhandaru Twitter Account  Sinu Bhandaru News  Sinu Bhandaru on Facebook
VP - Regulatory Affairs
Marcia Gaido
  Marcia Gaido LinkedIn Profile  Marcia Gaido Twitter Account  Marcia Gaido News  Marcia Gaido on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/27/2018: Aclima venture capital transaction
Next: 6/28/2018: Carisma Therapeutics venture capital transaction

 

Share this article

 


About Our VC Transactions Data

Our team works diligently to report on every notable VC transaction. All VC database entries reported here come from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary